showed that MUC1-C activates the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC) by interacting with PI3K p85, promoting tumor cell proliferation and significantly correlating with poor patient prognosis (55). This evidence concerns the gene MTOR and non-small cell lung carcinoma.